The zebrafish has emerged as a robust vertebrate model for studying cardiac electrophysiology and pharmacology, owing to its genetic tractability, optical transparency during early stages, and ...

Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent's has enrolled the first patient in the VITAL-EP study. The study is ...

Please provide your email address to receive an email when new articles are posted on . Advanced electrophysiology fellowship training is essential for operators conducting AF ablations. Complete ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond ...

Announcing major milestones for the company’s suite of pulse field ablation (PFA) devices in electrophysiology, Abbott Laboratories said it is advancing treatment for patients with abnormal heart ...

The use of the antipsychotic drugs quetiapine and haloperidol is associated with an increased risk of ventricular arrhythmias and sudden cardiac death (SCD) caused by drug-induced QT prolongation, ...

Management expects disposables and full system sales to grow in line with increased procedure acceptance, but notes that many procedures are currently performed under the pilot program or clinical ...

First Patient Enrolled at Ascension St. Vincent’s in Jacksonville, Florida Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent ...